{"text": ["Q1", "Earnings", "Scorecard", "and", "Analyst", "Reports", "for", "Exxon,", "Oracle", "&", "Eli", "Lilly"], "created_at": "2020-04-21 19:55:07"}
{"text": ["IMBRUVICA\u00ae", "(ibrutinib)", "Receives", "11th", "FDA", "Approval"], "created_at": "2020-04-21 19:22:00"}
{"text": ["Allergan\u2019s", "Acquisition", "by", "AbbVie", "Will", "Close", "Soon.", "Why", "One", "Analyst", "Just", "Downgraded", "Its", "Stock."], "created_at": "2020-04-21 17:36:00"}
{"text": ["8", "Safe", "High-Yield", "Dividend", "Stocks", "Offering", "5%", "or", "More"], "created_at": "2020-04-21 16:02:57"}
{"text": ["Form", "8.3", "-", "ABBVIE", "PLC"], "created_at": "2020-04-21 10:33:00"}
{"text": ["AbbVie", "Stock", "Falls", "3%"], "created_at": "2020-04-21 10:25:00"}
{"text": ["AbbVie-", "A", "Top", "Choice", "for", "a", "Post-Virus", "Portfolio"], "created_at": "2020-04-21 10:00:00"}
{"text": ["Form", "8.3", "-", "AbbVie", "Inc."], "created_at": "2020-04-21 09:35:00"}
